MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial

Bibliographic Details
Main Authors:	Collins, R, Armitage, J, Parish, S, Sleight, P, Peto, R, Collaborati, H
Format:	Journal article
Published:	2002

Similar Items

MRC/BHF Heart Protection Study - Reply
by: Collins, R, et al.
Published: (2002)

N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
by: Emberson, J, et al.
Published: (2005)

N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
by: Emberson, J, et al.
Published: (2005)

Comments on the MRC/BHF Heart Protection Study - Authors' reply
by: Collins, R, et al.
Published: (2003)

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
by: Collins, R, et al.
Published: (2003)

The MRC/BHF Heart Protection Study: preliminary results.
by: Collins, R, et al.
Published: (2002)

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
by: Heart Protection Study Collaborative Group
Published: (2002)

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
by: Emberson, JR, et al.
Published: (2007)

Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
by: Mihaylova, B, et al.
Published: (2005)

Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
by: Parish, S, et al.
Published: (2012)

MRC/BHF Heart Protection Study.
by: Vaughan, C, et al.
Published: (2002)

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
by: Collins, R, et al.
Published: (2004)

Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
by: Armitage, J, et al.
Published: (2000)

Effects of cholesterol-lowering therapy and antioxidant vitamin supplementation on the risk of stroke
by: Collins, R, et al.
Published: (2002)

MRC/BHF heart protection study (HPS): Mortality, cancer incidence and major vascular events during 4 years post-trial follow-up of HPS
by: Bulbulia, R, et al.
Published: (2007)

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial.
by: Bulbulia, R, et al.
Published: (2011)

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
by: Mihaylova, B, et al.
Published: (2005)

Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.
by: Armitage, J, et al.
Published: (2009)

Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
by: Mihaylova, B, et al.
Published: (2006)

Randomized trial of cholesterol-lowering, and of antioxidant vitamins, in 6,000 people with diabetes mellitus
by: Collins, R, et al.
Published: (2002)

Randomized trial of cholesterol-lowering and antioxidant vitamins in 7,000 high-risk individuals with LDL cholesterol below 120 mg/dl
by: Collins, R, et al.
Published: (2002)

Randomized trial of cholesterol-lowering and antioxidant vitamins in 5,000 women at high-risk of coronary heart disease
by: Collins, R, et al.
Published: (2002)

MRC BHFHeart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience
by: Meade, T, et al.
Published: (1999)

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
by: Armitage, J, et al.
Published: (2010)

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393].
by: Group, H
Published: (2005)

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]
Published: (2005-03-01)

Heart Protection Study - Reply
by: Collins, R, et al.
Published: (2003)

New analyses of Heart Protection Study - Reply
by: Collins, R, et al.
Published: (2004)

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
by: Baigent, C, et al.
Published: (1998)

No Impact of KIF6 Genotype on Vascular Risk or Statin Benefit in the Heart Protection Study
by: Hopewell, J, et al.
Published: (2009)

C-reactive protein in the Heart Protection Study Reply
by: Emberson, J, et al.
Published: (2011)

ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.
by: Collins, R, et al.
Published: (1993)

AFTER ISIS-3 - REPLY
by: Collins, R, et al.
Published: (1992)

20536. COMPLICACIONES NEUROLÓGICAS PARENQUIMATOSAS EN LA ENFERMEDAD DE BEHÇET
by: E. Estrada Palma, et al.
Published: (2024-11-01)

Assessing the impact sensitivity of explosives using the BHF-12A equipment
by: Rădeanu Cristian, et al.
Published: (2020-01-01)

Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials.
by: Clarke, R, et al.
Published: (2002)

Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
by: Clarke, R, et al.
Published: (2000)

Failure Investigation of Blank Holder Force (BHF) Control in The Outside Bracket For Front Seat
by: Rofan Yulian Romansyah, et al.
Published: (2023-06-01)

Effects of Folic Acid Plus Vitamin B-12 vs Placebo in Myocardial Infarction Survivors Reply
by: Armitage, J, et al.
Published: (2010)

The effect of vitamin D on chronic plaque psoriasis: A randomised, double-blind, placebo-controlled supplementation trial
by: M.A. Ingram, et al.
Published: (2016-06-01)